Cost-effectiveness studies: who is the key stakeholder?

Bone Joint J. 2019 Nov;101-B(11):1321-1324. doi: 10.1302/0301-620X.101B11.BJJ-2019-0954.

Authors

Sally Kerr¹, David Warwick², Fares S Haddad³

Affiliations

¹ Department of Trauma and Orthopaedics, University Hospitals Southampton NHS Foundation Trust, Southampton, UK.
² Department of Orthopaedics, University Hospitals Southampton NHS Foundation Trust, Southampton, UK.
³ The Bone & Joint Journal, University College London Hospitals, The Princess Grace Hospital, and The NIHR Biomedical Research Centre at UCLH, London, UK.

PMID: 31674245
DOI: 10.1302/0301-620X.101B11.BJJ-2019-0954

No abstract available

Publication types

Editorial

MeSH terms

Cost-Benefit Analysis
Fractures, Bone / economics
Fractures, Bone / rehabilitation
Fractures, Bone / surgery
Health Care Costs / statistics & numerical data*
Humans
Orthopedic Procedures / economics*
Orthopedic Procedures / rehabilitation
Quality-Adjusted Life Years